Abstract
Although community pharmacists are in a position to identify, record and report medication safety incidents, pharmacovigilance reporting rates by pharmacists are currently low. Changes within the pharmacy profession and to existing healthcare structures should help develop a culture that incorporates regular reporting of medication safety issues.
References
Rutter P, Borwn D, Howard J, et al. Pharmacists in pharmacovigilance: can increased diagnotic opportunity in community settings translate to better vigilance? Drug Saf. 2014;37(7):465–9.
Brown D, Portlock J, Rutter P. Services to support the healthy living pharmacy: a literature review. Int J Clin Pharm. 2012;34(3):399–409.
Stewart D, MacLure K, Paudyal V, et al. Non-medical prescribers and pharmacovigilance: participation, competence and future needs. Int J Clin Pharm. 2013;35(2):268–74.
Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, et al. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013;36(5):317–28.
Kroger E, Moisan J, Gregoire JP. Billing for cognitive services: understanding Quebec pharmacists’ behaviour. Ann Pharmacother. 2000;34(3):309–16.
Chan P, Grindrod KA, Bougher D, et al. A systematic review of remuneration systems for clinical pharmacy services. Can Pharm J. 2009;141(2):102–12.
Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143(1):37–42.
Austin Z, Gregory PAM, Martin JC. Negotiation of interprofessional culture shock: the experiences of pharmacists who become physicians. J Interprof Care. 2007;21(1):83–93.
Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–31.
Jadeja M, McCreedy C. Positive effect of new medicine service on community yellow card reporting. Pharm J. 2012;289:159.
Richardson E, Pollock AM. Community pharmacy: moving from dispensing to diagnosis and treatment. Br Med J. 2010;340:c2298.
Disclosure
This article was adapted from Drug Safety 2014;37(7):465–9 [1] by salaried employees of Adis/Springer, and was not supported by any external funding.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Adis Medical Writers. Changes are required to help community pharmacists become more involved in reporting medication safety issues. Drugs Ther Perspect 31, 165–166 (2015). https://doi.org/10.1007/s40267-015-0186-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-015-0186-0